In an AML-specific dataset, USP15 expression was significantly higher in patients with AML carrying various genetic abnormalities compared to the normal human CD34+-enriched BM hematopoietic precursors (Figure 5C) (Bagger et al., 2013) (Hemaexplorer; http://servers.binf.ku.dk/bloodspot/). The gene discussed is CD34; the disease is acute myeloid leukemia.